Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Evaluation of IgA1 O-glycosylation in Henoch-Schönlein Purpura Nephritis Using Mass Spectrometry.

Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Tajiri M, Wada Y, Nonomura N.

Transplant Proc. 2019 Jun;51(5):1481-1487. doi: 10.1016/j.transproceed.2019.01.122. Epub 2019 May 10.

PMID:
31084922
2.

Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.

Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.

Biochem Biophys Res Commun. 2019 Jan 22;508(4):1106-1112. doi: 10.1016/j.bbrc.2018.12.014. Epub 2018 Dec 13.

PMID:
30553446
3.

Tolvaptan Efficiently Reduces Intracellular Fluid: Working Toward a Potential Treatment Option for Cellular Edema.

Kawabata H, Iwatani H, Yamamichi Y, Shirahase K, Nagai N, Isaka Y.

Intern Med. 2019 Mar 1;58(5):639-642. doi: 10.2169/internalmedicine.0993-18. Epub 2018 Nov 19.

4.

Tolvaptan promotes urinary excretion of sodium and urea: a retrospective cohort study.

Minami S, Hamano T, Iwatani H, Mizui M, Kimura Y, Isaka Y.

Clin Exp Nephrol. 2018 Jun;22(3):550-561. doi: 10.1007/s10157-017-1475-9. Epub 2017 Oct 20.

PMID:
29052786
5.

Myeloperoxidase/HLA Class II Complexes Recognized by Autoantibodies in Microscopic Polyangiitis.

Hiwa R, Ohmura K, Arase N, Jin H, Hirayasu K, Kohyama M, Suenaga T, Saito F, Terao C, Atsumi T, Iwatani H, Mimori T, Arase H.

Arthritis Rheumatol. 2017 Oct;69(10):2069-2080. doi: 10.1002/art.40170. Epub 2017 Aug 25.

6.

Continuous Hemodiafiltration with an AN69ST Hemofilter (AN69ST-CHDF) as FGF-23-Lowering Therapy.

Yamato M, Minematsu Y, Ikemiya Y, Shibata J, Fujii J, Minato T, Miyagawa S, Takaori K, Tomiyama Y, Nagayama I, Wada A, Ito T, Iwatani H.

Clin Lab. 2016 Dec 1;62(12):2349-2354. doi: 10.7754/Clin.Lab.2016.160423.

PMID:
28164555
7.

Clozapine improved the syndrome of inappropriate antidiuretic hormone secretion in a patient with treatment-resistant schizophrenia.

Fujimoto M, Hashimoto R, Yamamori H, Yasuda Y, Ohi K, Iwatani H, Isaka Y, Takeda M.

Psychiatry Clin Neurosci. 2016 Oct;70(10):469. doi: 10.1111/pcn.12435. Epub 2016 Sep 20. No abstract available.

8.

IFI27 Is a Useful Genetic Marker for Diagnosis of Immunoglobulin A Nephropathy and Membranous Nephropathy Using Peripheral Blood.

Nagasawa Y, Okuzaki D, Muso E, Yamamoto R, Shinzawa M, Iwasaki Y, Iwatani H, Nakanishi T, Isaka Y, Nojima H.

PLoS One. 2016 Apr 21;11(4):e0153252. doi: 10.1371/journal.pone.0153252. eCollection 2016.

9.

Minimal Change Nephrotic Syndrome Which Was Most Likely Caused by Chronic Sinusitis.

Iwatani H, Mori D, Yamamoto S, Nakano C, Yamamoto R, Masumura C, Shikina T, Imai T, Inohara H, Rakugi H, Isaka Y.

Intern Med. 2015;54(18):2373-5. doi: 10.2169/internalmedicine.54.4480. Epub 2015 Sep 15.

10.

Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney disease.

Sakaguchi Y, Iwatani H, Hamano T, Tomida K, Kawabata H, Kusunoki Y, Shimomura A, Matsui I, Hayashi T, Tsubakihara Y, Isaka Y, Rakugi H.

Kidney Int. 2015 Oct;88(4):833-42. doi: 10.1038/ki.2015.165. Epub 2015 Jun 10.

PMID:
26061542
11.

Urine osmolarity predicts the body weight-reduction response to tolvaptan in chronic kidney disease patients: a retrospective, observational study.

Iwatani H, Kawabata H, Sakaguchi Y, Yamamoto R, Hamano T, Rakugi H, Isaka Y.

Nephron. 2015;130(1):8-12. doi: 10.1159/000381859. Epub 2015 Apr 30.

PMID:
25926290
12.

Size distribution studies of 137Cs in river water in the Abukuma Riverine system following the Fukushima Dai-ichi Nuclear Power Plant accident.

Sakaguchi A, Tanaka K, Iwatani H, Chiga H, Fan Q, Onda Y, Takahashi Y.

J Environ Radioact. 2015 Jan;139:379-389. doi: 10.1016/j.jenvrad.2014.05.011. Epub 2014 Jun 12.

PMID:
24929977
13.

Size-dependent distribution of radiocesium in riverbed sediments and its relevance to the migration of radiocesium in river systems after the Fukushima Daiichi Nuclear Power Plant accident.

Tanaka K, Iwatani H, Sakaguchi A, Fan Q, Takahashi Y.

J Environ Radioact. 2015 Jan;139:390-397. doi: 10.1016/j.jenvrad.2014.05.002. Epub 2014 May 27.

PMID:
24874435
14.

CD16+CD56+ cells are a potential culprit for hematuria in IgA nephropathy.

Iwatani H, Nagasawa Y, Yamamoto R, Iio K, Mizui M, Horii A, Kitahara T, Inohara H, Kumanogoh A, Imai E, Rakugi H, Isaka Y.

Clin Exp Nephrol. 2015 Apr;19(2):216-24. doi: 10.1007/s10157-014-0968-z. Epub 2014 May 6.

PMID:
24798970
15.

Autophagic clearance of mitochondria in the kidney copes with metabolic acidosis.

Namba T, Takabatake Y, Kimura T, Takahashi A, Yamamoto T, Matsuda J, Kitamura H, Niimura F, Matsusaka T, Iwatani H, Matsui I, Kaimori J, Kioka H, Isaka Y, Rakugi H.

J Am Soc Nephrol. 2014 Oct;25(10):2254-66. doi: 10.1681/ASN.2013090986. Epub 2014 Apr 3.

16.

Periodontal disease bacteria specific to tonsil in IgA nephropathy patients predicts the remission by the treatment.

Nagasawa Y, Iio K, Fukuda S, Date Y, Iwatani H, Yamamoto R, Horii A, Inohara H, Imai E, Nakanishi T, Ohno H, Rakugi H, Isaka Y.

PLoS One. 2014 Jan 28;9(1):e81636. doi: 10.1371/journal.pone.0081636. eCollection 2014.

17.

ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy.

Teranishi J, Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Okada N, Moriyama T, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y.

J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):633-41. doi: 10.1177/1470320313515036. Epub 2014 Jan 22.

PMID:
24452035
18.

Investigation of spatial distribution of radiocesium in a paddy field as a potential sink.

Tanaka K, Iwatani H, Takahashi Y, Sakaguchi A, Yoshimura K, Onda Y.

PLoS One. 2013 Nov 15;8(11):e80794. doi: 10.1371/journal.pone.0080794. eCollection 2013.

19.

Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats.

Matsui I, Hamano T, Mikami S, Inoue K, Shimomura A, Nagasawa Y, Michigami T, Ohnishi T, Fujii N, Nakano C, Kusunoki Y, Kitamura H, Iwatani H, Takabatake Y, Kaimori JY, Matsuba G, Okoshi K, Kimura-Suda H, Tsubakihara Y, Rakugi H, Isaka Y.

Am J Physiol Renal Physiol. 2013 Mar 15;304(6):F751-60. doi: 10.1152/ajprenal.00329.2012. Epub 2013 Jan 23.

20.

Quantitative change of IgA hinge O-glycan composition is a novel marker of therapeutic responses of IgA nephropathy.

Iwatani H, Inoue T, Wada Y, Nagasawa Y, Yamamoto R, Iijima H, Takehara T, Imai E, Rakugi H, Isaka Y.

Biochem Biophys Res Commun. 2012 Nov 23;428(3):339-42. doi: 10.1016/j.bbrc.2012.10.049. Epub 2012 Oct 23.

PMID:
23098908
21.

Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.

Inoue T, Iijima H, Tajiri M, Shinzaki S, Shiraishi E, Hiyama S, Mukai A, Nakajima S, Iwatani H, Nishida T, Mizushima T, Yasui T, Isaka Y, Kanto T, Tsujii M, Miyoshi E, Wada Y, Takehara T.

Inflamm Bowel Dis. 2012 Sep;18(9):1723-34. doi: 10.1002/ibd.22876. Epub 2012 Jan 12.

PMID:
22241690
22.

Gene polymorphisms contributing to hypertension in immunoglobulin A nephropathy.

Shinzawa M, Yamamoto R, Nagasawa Y, Shoji T, Obi Y, Namba T, Kitamura H, Kaneko T, Okada N, Iwatani H, Yamauchi A, Tsubakihara Y, Imai E, Isaka Y, Rakugi H.

Clin Exp Nephrol. 2012 Apr;16(2):250-8. doi: 10.1007/s10157-011-0553-7. Epub 2011 Nov 11.

PMID:
22072187
23.

Self-reported sleep duration and prediction of proteinuria: a retrospective cohort study.

Yamamoto R, Nagasawa Y, Iwatani H, Shinzawa M, Obi Y, Teranishi J, Ishigami T, Yamauchi-Takihara K, Nishida M, Rakugi H, Isaka Y, Moriyama T.

Am J Kidney Dis. 2012 Mar;59(3):343-55. doi: 10.1053/j.ajkd.2011.08.032. Epub 2011 Oct 22.

PMID:
22019276
24.

Microarray analysis of tonsils of IgA nephropathy patients.

Iwatani H, Iio K, Nagasawa Y, Yamamoto R, Horii A, Okuzaki D, Inohara H, Nojima H, Imai E, Rakugi H, Isaka Y.

Adv Otorhinolaryngol. 2011;72:75-8. doi: 10.1159/000324611. Epub 2011 Aug 18.

PMID:
21865695
25.

Urinary type IV collagen in nondiabetic kidney disease.

Furumatsu Y, Nagasawa Y, Shoji T, Yamamoto R, Iio K, Matsui I, Takabatake Y, Kaimori JY, Iwatani H, Kaneko T, Tsubakihara Y, Imai E, Isaka Y, Rakugi H.

Nephron Clin Pract. 2011;117(2):c160-6. doi: 10.1159/000319794. Epub 2010 Aug 12.

PMID:
20699621
26.

Cigarette smoking and progression of IgA nephropathy.

Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, Inoue K, Uehata T, Kaneko T, Okada N, Moriyama T, Horio M, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y.

Am J Kidney Dis. 2010 Aug;56(2):313-24. doi: 10.1053/j.ajkd.2010.02.351. Epub 2010 May 14.

PMID:
20471735
27.

Kidney repair using stem cells: myth or reality as a therapeutic option?

Iwatani H, Imai E.

J Nephrol. 2010 Mar-Apr;23(2):143-6. Review.

PMID:
20175054
28.

Microarray analysis of tonsils in immunoglobulin A nephropathy patients.

Iio K, Nagasawa Y, Iwatani H, Yamamoto R, Horii A, Okuzaki D, Furumatsu Y, Inohara H, Nojima H, Imai E, Isaka Y, Rakugi H.

Biochem Biophys Res Commun. 2010 Mar 19;393(4):565-70. doi: 10.1016/j.bbrc.2010.01.120. Epub 2010 Feb 6.

PMID:
20138841
29.

E-cadherin and claudin-4 expression has circadian rhythm in adult rat kidney.

Yamato M, Ito T, Iwatani H, Yamato M, Imai E, Rakugi H.

J Nephrol. 2010 Jan-Feb;23(1):102-10.

PMID:
20091493
30.

Specialist care and improved long-term survival of dialysis patients.

Furumatsu Y, Nagasawa Y, Yamamoto R, Iio K, Iwatani H, Matsui I, Takabatake Y, Kawada N, Shoji T, Imai E, Isaka Y, Rakugi H.

Nephrol Dial Transplant. 2010 Jun;25(6):1930-5. doi: 10.1093/ndt/gfp738. Epub 2010 Jan 8.

PMID:
20061314
31.

Kid-1 participates in regulating ERK phosphorylation as a part of the circadian clock output in rat kidney.

Yamato M, Ishida N, Iwatani H, Yamato M, Rakugi H, Ito T.

J Recept Signal Transduct Res. 2009;29(2):94-9. doi: 10.1080/10799890902830783.

PMID:
19519174
32.

Massive and rapid left ventricular calcification.

Iwatani H, Tomida K, Nagasawa Y, Imai E, Rakugi H, Isaka Y.

NDT Plus. 2009 Jun;2(3):259-60. doi: 10.1093/ndtplus/sfp018. Epub 2009 Mar 12. No abstract available.

33.

Early plasma exchange for progressive liver failure in recipients of adult-to-adult living-related liver transplants.

Yamamoto R, Nagasawa Y, Marubashi S, Furumatsu Y, Iwatani H, Iio K, Matsui I, Dono K, Imai E, Monden M, Isaka Y.

Blood Purif. 2009;28(1):40-6. doi: 10.1159/000210036. Epub 2009 Mar 27.

PMID:
19325238
34.

Valvular injury in a patient with PR3-ANCA-associated glomerulonephritis.

Iwatani H, Nagasawa Y, Oka K, Isaka Y, Imai E.

Nat Clin Pract Nephrol. 2008 Oct;4(10):576-82. doi: 10.1038/ncpneph0943. Epub 2008 Sep 2.

PMID:
18762796
35.

Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics.

Tanaka H, Nagasawa Y, Matsui I, Hamano T, Iwatani H, Kawada N, Horio M, Ito T, Isaka Y, Imai E.

Clin Exp Nephrol. 2009 Feb;13(1):61-5. doi: 10.1007/s10157-008-0067-0. Epub 2008 Jun 24.

PMID:
18574553
36.

Assessment of coronary stenosis by a 16-slice MDCT scanner in asymptomatic diabetic patients starting dialysis therapy.

Iio K, Nagasawa Y, Kimura T, Yamasaki K, Takeda Y, Hamano T, Iwatani H, Sumitsuji S, Nagai Y, Ito T, Imai E, Hayashi T.

Nephron Clin Pract. 2008;109(2):c72-9. doi: 10.1159/000139992. Epub 2008 Jun 18.

PMID:
18560241
37.

Acute renal failure with severe loin pain after anaerobic exercise (ALPE): detection of patchy renal ischaemia by contrast-enhanced colour Doppler.

Furumatsu Y, Nagasawa Y, Hamano T, Iwatani H, Imai E.

NDT Plus. 2008 Apr;1(2):120-121. doi: 10.1093/ndtplus/sfm011. Epub 2007 Dec 19. No abstract available.

38.

Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan.

Furumatsu Y, Nagasawa Y, Hamano T, Iwatani H, Iio K, Shoji T, Ito T, Tsubakihara Y, Imai E.

Nephrol Dial Transplant. 2008 Mar;23(3):984-90. Epub 2007 Oct 23.

PMID:
17956890
39.

The continuing story of renal repair with stem cells.

Imai E, Iwatani H.

J Am Soc Nephrol. 2007 Sep;18(9):2423-4. Epub 2007 Aug 15. Review. No abstract available.

40.

Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice.

Ohashi K, Iwatani H, Kihara S, Nakagawa Y, Komura N, Fujita K, Maeda N, Nishida M, Katsube F, Shimomura I, Ito T, Funahashi T.

Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1910-7. Epub 2007 Jul 12.

PMID:
17626903
41.

Structural and functional evolution of three cardiac natriuretic peptides.

Inoue K, Sakamoto T, Yuge S, Iwatani H, Yamagami S, Tsutsumi M, Hori H, Cerra MC, Tota B, Suzuki N, Okamoto N, Takei Y.

Mol Biol Evol. 2005 Dec;22(12):2428-34. Epub 2005 Aug 24.

PMID:
16120806
42.

[Successful treatment of MPO-ANCA associated glomerulonephritis with high dose intravenous immunoglobulin].

Namba T, Mikami S, Yamato M, Nagatoya K, Iwatani H, Nagasawa Y, Ito T, Imai E.

Nihon Naika Gakkai Zasshi. 2005 Jul 10;94(7):1402-5. Japanese. No abstract available.

PMID:
16097598
43.

A case of Wegener's granulomatosis with pulmonary bleeding successfully treated with double filtration plasmapheresis (DFPP).

Iwatani H, Uzu T, Kakihara M, Nakayama Y, Kanasaki K, Yamato M, Hirai Y, Umimoto K, Yamauchi A.

Clin Exp Nephrol. 2004 Dec;8(4):369-74.

PMID:
15619039
44.

Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury.

Wang Y, Iwatani H, Ito T, Horimoto N, Yamato M, Matsui I, Imai E, Hori M.

Biochem Biophys Res Commun. 2004 Dec 17;325(3):961-7.

PMID:
15541383
45.

Hematopoietic and nonhematopoietic potentials of Hoechst(low)/side population cells isolated from adult rat kidney.

Iwatani H, Ito T, Imai E, Matsuzaki Y, Suzuki A, Yamato M, Okabe M, Hori M.

Kidney Int. 2004 May;65(5):1604-14.

46.

Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin.

Nakajima H, Takenaka M, Kaimori JY, Hamano T, Iwatani H, Sugaya T, Ito T, Hori M, Imai E.

J Am Soc Nephrol. 2004 Feb;15(2):276-85.

47.

Platelet-derived growth factor plays a critical role to convert bone marrow cells into glomerular mesangial-like cells.

Suzuki A, Iwatani H, Ito T, Imai E, Okabe M, Nakamura H, Isaka Y, Yamato M, Hori M.

Kidney Int. 2004 Jan;65(1):15-24.

48.

Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats.

Suzuki A, Ito T, Imai E, Yamato M, Iwatani H, Kawachi H, Hori M.

J Am Soc Nephrol. 2003 Apr;14(4):981-91.

49.
50.

Minimal-change nephrotic syndrome associated with mixed connective-tissue disease.

Uzu T, Iwatani H, Ko M, Yamato M, Takahara K, Yamauchi A.

Nephrol Dial Transplant. 2001 Jun;16(6):1299-300. No abstract available.

PMID:
11390743

Supplemental Content

Loading ...
Support Center